Drug intelligence / Profile preview

2-(2-hydroxy-phenyl)-1h-indole-5-carboxamidine

Development stage: Unknown
Modality: Small Molecules

Overview

2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine is an experimental small molecule belonging to the class of 2-phenylindoles. It has not been approved for clinical use in any country and is not associated with any marketed brand names. The compound acts as an inhibitor of serine protease 1, suggesting a mechanism involving interference with serine protease-mediated biological processes. No specific therapeutic indication or disease target has been established, and there are no reported clinical trials beyond preclinical or experimental stages[1][3]. Its molecular formula is C15H14N3O.

Other names: [2-(2-hydroxyphenyl)-1H-indol-5-yl](imino)methanaminium

Targets

PRSS1 (Trypsin family)

Beyond the preview

Go deeper on 2-(2-hydroxy-phenyl)-1h-indole-5-carboxamidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-(2-hydroxy-phenyl)-1h-indole-5-carboxamidine.

Explore the full profile